The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Friday will be mostly dry with sunny spells for much of the UK. Temperatures will be mild across the country.
Some famous Liberal Democrat names will be fighting for their political lives in the election, now just over two months away.
One year on from the disappearance of Malaysia Airlines flight MH370 and relatives of the victims are continuing to fight for answers.